A class action lawsuit has been filed against Inspire Medical Systems Inc. on behalf of investors who suffered losses between August 6, 2024, and August 4, 2025, due to alleged securities fraud. The complaint alleges that the company misled investors about the launch of its new product, Inspire V. Contrary to positive statements from company representatives, the launch reportedly faced significant issues, including poor demand, excess inventory at providers, and reluctance among providers to transition to the new treatment. Additionally, the lawsuit claims Inspire failed to complete essential tasks for a successful product launch, such as training treatment centers, setting up key IT systems, updating insurer claims software, and ensuring Medicare reimbursement was in place. These failures were not disclosed to investors until later, allegedly causing financial harm. The legal action seeks to recover damages for affected shareholders.